The top 10 projected best-selling medications in 2026, including GLP-1 drugs and AbbVie's Skyrizi, have expected global sales reaching up to $31 billiion.
Q. I have something like varicose veins in my nose that cause frequent nosebleeds. My nose is often dry regardless of weather conditions.
Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Social support can improve the odds of successful weight loss. AnnaLee Canario and Dacia Benjamin say their friendship is the secret to their success with GLP-1s.
Both semaglutide and tirzepatide should help people with Type 2 diabetes lower their HbA1c, a measure of blood glucose over ...
Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, Brazil and Mexico in 2025, Chief Financial Officer Lucas Montarce said on Monday.
A nutritionist who lost 100 pounds using a diet he designed himself claims apples "do the exact same thing" as weight-loss ...
Eli Lilly plans to globally launch its diabetes and weight-loss drug, Mounjaro, in countries including China, India, Brazil, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results